CELESTICA INC (CLS) Fundamental Analysis & Valuation

NYSE:CLS • CA15101Q2071

Current stock price

284.3 USD
+10.72 (+3.92%)
At close:
283 USD
-1.3 (-0.46%)
Pre-Market:

This CLS fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

8

1. CLS Profitability Analysis

1.1 Basic Checks

  • In the past year CLS was profitable.
  • In the past year CLS had a positive cash flow from operations.
  • In the past 5 years CLS has always been profitable.
  • Each year in the past 5 years CLS had a positive operating cash flow.
CLS Yearly Net Income VS EBIT VS OCF VS FCFCLS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 200M 400M 600M 800M 1B

1.2 Ratios

  • The Return On Assets of CLS (11.54%) is better than 92.74% of its industry peers.
  • CLS has a Return On Equity of 37.56%. This is amongst the best in the industry. CLS outperforms 96.77% of its industry peers.
  • CLS has a better Return On Invested Capital (24.36%) than 100.00% of its industry peers.
  • The Average Return On Invested Capital over the past 3 years for CLS is significantly above the industry average of 8.58%.
  • The last Return On Invested Capital (24.36%) for CLS is above the 3 year average (17.88%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 11.54%
ROE 37.56%
ROIC 24.36%
ROA(3y)7.61%
ROA(5y)5.53%
ROE(3y)24.65%
ROE(5y)17.94%
ROIC(3y)17.88%
ROIC(5y)13.64%
CLS Yearly ROA, ROE, ROICCLS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10 20 30

1.3 Margins

  • With a decent Profit Margin value of 6.72%, CLS is doing good in the industry, outperforming 73.39% of the companies in the same industry.
  • CLS's Profit Margin has improved in the last couple of years.
  • The Operating Margin of CLS (7.80%) is better than 72.58% of its industry peers.
  • In the last couple of years the Operating Margin of CLS has grown nicely.
  • The Gross Margin of CLS (12.06%) is worse than 75.81% of its industry peers.
  • In the last couple of years the Gross Margin of CLS has grown nicely.
Industry RankSector Rank
OM 7.8%
PM (TTM) 6.72%
GM 12.06%
OM growth 3Y32.38%
OM growth 5Y32.85%
PM growth 3Y49.6%
PM growth 5Y44.64%
GM growth 3Y11.17%
GM growth 5Y11.4%
CLS Yearly Profit, Operating, Gross MarginsCLS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2 4 6 8 10

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

8

2. CLS Health Analysis

2.1 Basic Checks

  • The Return on Invested Capital (ROIC) is well above the Cost of Capital (WACC), so CLS is creating value.
  • CLS has less shares outstanding than it did 1 year ago.
  • The number of shares outstanding for CLS has been reduced compared to 5 years ago.
  • CLS has a better debt/assets ratio than last year.
CLS Yearly Shares OutstandingCLS Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 50M 100M
CLS Yearly Total Debt VS Total AssetsCLS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2B 4B 6B

2.2 Solvency

  • CLS has an Altman-Z score of 6.45. This indicates that CLS is financially healthy and has little risk of bankruptcy at the moment.
  • With a decent Altman-Z score value of 6.45, CLS is doing good in the industry, outperforming 79.03% of the companies in the same industry.
  • The Debt to FCF ratio of CLS is 1.69, which is an excellent value as it means it would take CLS, only 1.69 years of fcf income to pay off all of its debts.
  • CLS has a Debt to FCF ratio of 1.69. This is amongst the best in the industry. CLS outperforms 82.26% of its industry peers.
  • CLS has a Debt/Equity ratio of 0.34. This is a healthy value indicating a solid balance between debt and equity.
  • CLS has a Debt to Equity ratio of 0.34. This is in the lower half of the industry: CLS underperforms 63.71% of its industry peers.
  • Although CLS's pure debt/equity ratio does not look good, it has limited outstanding debt compared to the Free Cash Flow. We will not put too much weight on the debt/equity number as it may be because of low equity, which could be a consequence of a share buyback program for instance. This needs to be investigated.
Industry RankSector Rank
Debt/Equity 0.34
Debt/FCF 1.69
Altman-Z 6.45
ROIC/WACC2.94
WACC8.3%
CLS Yearly LT Debt VS Equity VS FCFCLS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 500M 1B 1.5B 2B

2.3 Liquidity

  • A Current Ratio of 1.44 indicates that CLS should not have too much problems paying its short term obligations.
  • CLS has a worse Current ratio (1.44) than 75.00% of its industry peers.
  • CLS has a Quick Ratio of 1.44. This is a bad value and indicates that CLS is not financially healthy enough and could expect problems in meeting its short term obligations.
  • CLS has a worse Quick ratio (0.88) than 84.68% of its industry peers.
  • CLS does not score too well on the current and quick ratio evaluation. However, as it has excellent solvency and profitability, these ratios do not necessarly indicate liquidity issues and need to be evaluated against the specifics of the business.
Industry RankSector Rank
Current Ratio 1.44
Quick Ratio 0.88
CLS Yearly Current Assets VS Current LiabilitesCLS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 1B 2B 3B 4B 5B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

9

3. CLS Growth Analysis

3.1 Past

  • CLS shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 54.59%, which is quite impressive.
  • Measured over the past years, CLS shows a very strong growth in Earnings Per Share. The EPS has been growing by 43.67% on average per year.
  • Looking at the last year, CLS shows a very strong growth in Revenue. The Revenue has grown by 28.46%.
  • CLS shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 16.61% yearly.
EPS 1Y (TTM)54.59%
EPS 3Y46.94%
EPS 5Y43.67%
EPS Q2Q%70.27%
Revenue 1Y (TTM)28.46%
Revenue growth 3Y19.56%
Revenue growth 5Y16.61%
Sales Q2Q%43.57%

3.2 Future

  • The Earnings Per Share is expected to grow by 40.90% on average over the next years. This is a very strong growth
  • CLS is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 36.42% yearly.
EPS Next Y48.55%
EPS Next 2Y46.28%
EPS Next 3Y40.9%
EPS Next 5YN/A
Revenue Next Year42.21%
Revenue Next 2Y41.08%
Revenue Next 3Y36.42%
Revenue Next 5YN/A

3.3 Evolution

  • The EPS growth rate is stable: in the next years the growth will be about the same than in the last years.
  • The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
CLS Yearly Revenue VS EstimatesCLS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 10B 20B 30B
CLS Yearly EPS VS EstimatesCLS Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 5 10 15

More info and screens

Find the best growth stocksShow best growing peers

4

4. CLS Valuation Analysis

4.1 Price/Earnings Ratio

  • CLS is valuated quite expensively with a Price/Earnings ratio of 46.91.
  • Compared to the rest of the industry, the Price/Earnings ratio of CLS is on the same level as its industry peers.
  • Compared to an average S&P500 Price/Earnings ratio of 25.73, CLS is valued quite expensively.
  • With a Price/Forward Earnings ratio of 31.58, CLS can be considered very expensive at the moment.
  • The rest of the industry has a similar Price/Forward Earnings ratio as CLS.
  • Compared to an average S&P500 Price/Forward Earnings ratio of 23.72, CLS is valued a bit more expensive.
Industry RankSector Rank
PE 46.91
Fwd PE 31.58
CLS Price Earnings VS Forward Price EarningsCLS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40

4.2 Price Multiples

  • CLS's Enterprise Value to EBITDA is on the same level as the industry average.
  • CLS's Price/Free Cash Flow is on the same level as the industry average.
Industry RankSector Rank
P/FCF 71.32
EV/EBITDA 28.79
CLS Per share dataCLS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 20 40 60 80 100

4.3 Compensation for Growth

  • CLS's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
  • CLS has an outstanding profitability rating, which may justify a higher PE ratio.
  • CLS's earnings are expected to grow with 40.90% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.97
PEG (5Y)1.07
EPS Next 2Y46.28%
EPS Next 3Y40.9%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. CLS Dividend Analysis

5.1 Amount

  • No dividends for CLS!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

CLS Fundamentals: All Metrics, Ratios and Statistics

CELESTICA INC

NYSE:CLS (3/19/2026, 8:04:00 PM)

Premarket: 283 -1.3 (-0.46%)

284.3

+10.72 (+3.92%)

Chartmill FA Rating
GICS IndustryGroupTechnology Hardware & Equipment
GICS IndustryElectronic Equipment, Instruments & Components
Earnings (Last)01-28
Earnings (Next)04-22
Inst Owners72.98%
Inst Owner Change3.66%
Ins Owners0.79%
Ins Owner Change50.64%
Market Cap32.69B
Revenue(TTM)12.39B
Net Income(TTM)832.50M
Analysts81.18
Price Target270.25 (-4.94%)
Short Float %3.64%
Short Ratio1.53
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)6.27%
Min EPS beat(2)5.95%
Max EPS beat(2)6.6%
EPS beat(4)4
Avg EPS beat(4)7.73%
Min EPS beat(4)5.95%
Max EPS beat(4)11.71%
EPS beat(8)8
Avg EPS beat(8)9.02%
EPS beat(12)12
Avg EPS beat(12)8.99%
EPS beat(16)16
Avg EPS beat(16)8.6%
Revenue beat(2)2
Avg Revenue beat(2)4.43%
Min Revenue beat(2)3.86%
Max Revenue beat(2)5%
Revenue beat(4)4
Avg Revenue beat(4)4.69%
Min Revenue beat(4)2.5%
Max Revenue beat(4)7.4%
Revenue beat(8)7
Avg Revenue beat(8)3.75%
Revenue beat(12)11
Avg Revenue beat(12)3.24%
Revenue beat(16)15
Avg Revenue beat(16)3.66%
PT rev (1m)-0.2%
PT rev (3m)8.39%
EPS NQ rev (1m)0%
EPS NQ rev (3m)13.82%
EPS NY rev (1m)7.19%
EPS NY rev (3m)7.19%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)10.31%
Revenue NY rev (1m)7.29%
Revenue NY rev (3m)7.33%
Valuation
Industry RankSector Rank
PE 46.91
Fwd PE 31.58
P/S 2.64
P/FCF 71.32
P/OCF 49.56
P/B 14.75
P/tB 20.21
EV/EBITDA 28.79
EPS(TTM)6.06
EY2.13%
EPS(NY)9
Fwd EY3.17%
FCF(TTM)3.99
FCFY1.4%
OCF(TTM)5.74
OCFY2.02%
SpS107.78
BVpS19.28
TBVpS14.06
PEG (NY)0.97
PEG (5Y)1.07
Graham Number51.27
Profitability
Industry RankSector Rank
ROA 11.54%
ROE 37.56%
ROCE 29.51%
ROIC 24.36%
ROICexc 29.78%
ROICexgc 38.37%
OM 7.8%
PM (TTM) 6.72%
GM 12.06%
FCFM 3.7%
ROA(3y)7.61%
ROA(5y)5.53%
ROE(3y)24.65%
ROE(5y)17.94%
ROIC(3y)17.88%
ROIC(5y)13.64%
ROICexc(3y)21.34%
ROICexc(5y)16.25%
ROICexgc(3y)28.33%
ROICexgc(5y)22.11%
ROCE(3y)21.66%
ROCE(5y)16.53%
ROICexgc growth 3Y42.82%
ROICexgc growth 5Y38.52%
ROICexc growth 3Y48.19%
ROICexc growth 5Y40.13%
OM growth 3Y32.38%
OM growth 5Y32.85%
PM growth 3Y49.6%
PM growth 5Y44.64%
GM growth 3Y11.17%
GM growth 5Y11.4%
F-Score7
Asset Turnover1.72
Health
Industry RankSector Rank
Debt/Equity 0.34
Debt/FCF 1.69
Debt/EBITDA 0.66
Cap/Depr 114.51%
Cap/Sales 1.62%
Interest Coverage 17.86
Cash Conversion 57.76%
Profit Quality 55.05%
Current Ratio 1.44
Quick Ratio 0.88
Altman-Z 6.45
F-Score7
WACC8.3%
ROIC/WACC2.94
Cap/Depr(3y)107.56%
Cap/Depr(5y)87.85%
Cap/Sales(3y)1.66%
Cap/Sales(5y)1.48%
Profit Quality(3y)69.38%
Profit Quality(5y)101.2%
High Growth Momentum
Growth
EPS 1Y (TTM)54.59%
EPS 3Y46.94%
EPS 5Y43.67%
EPS Q2Q%70.27%
EPS Next Y48.55%
EPS Next 2Y46.28%
EPS Next 3Y40.9%
EPS Next 5YN/A
Revenue 1Y (TTM)28.46%
Revenue growth 3Y19.56%
Revenue growth 5Y16.61%
Sales Q2Q%43.57%
Revenue Next Year42.21%
Revenue Next 2Y41.08%
Revenue Next 3Y36.42%
Revenue Next 5YN/A
EBIT growth 1Y69.46%
EBIT growth 3Y58.27%
EBIT growth 5Y54.91%
EBIT Next Year74.41%
EBIT Next 3Y58.82%
EBIT Next 5YN/A
FCF growth 1Y51.25%
FCF growth 3Y34.37%
FCF growth 5Y19.66%
OCF growth 1Y39.16%
OCF growth 3Y30.33%
OCF growth 5Y22.45%

CELESTICA INC / CLS Fundamental Analysis FAQ

Can you provide the ChartMill fundamental rating for CELESTICA INC?

ChartMill assigns a fundamental rating of 7 / 10 to CLS.


What is the valuation status of CELESTICA INC (CLS) stock?

ChartMill assigns a valuation rating of 4 / 10 to CELESTICA INC (CLS). This can be considered as Fairly Valued.


What is the profitability of CLS stock?

CELESTICA INC (CLS) has a profitability rating of 8 / 10.


What is the valuation of CELESTICA INC based on its PE and PB ratios?

The Price/Earnings (PE) ratio for CELESTICA INC (CLS) is 46.91 and the Price/Book (PB) ratio is 14.75.


How financially healthy is CELESTICA INC?

The financial health rating of CELESTICA INC (CLS) is 8 / 10.